Dr. Chapa’s Clinical Pearls.

Dr. Chapa’s Clinical Pearls
undefined
Feb 17, 2025 • 30min

Excessive Maternal Wt Gain (gwg) = Stillbirth?

One in five women in the U.S. begin pregnancy with a BMI of 30 or higher. Excessive weight gain during this time can lead to serious complications like gestational diabetes and shoulder dystocia. Surprisingly, the link between high maternal weight gain and stillbirth risk is complex. While guidelines recommend monitoring based on pre-pregnancy BMI, the reasons for this approach may not be as straightforward as expected. The discussion uncovers startling data and insights on maternal health throughout pregnancy!
undefined
Feb 15, 2025 • 35min

PUR and Peppermint Oil?

Estimates of Postpartum Urinary Retention (PUR) incidence vary widely from 1.5% to 17.9%, with undiagnosed cases making the true incidence difficult to determine. A postvoid residual (PVR) volume of <150 mL is typically considered appropriate for normal bladder emptying, but this has been in the nonpregnant/non-postpartum population. In this group, some have proposed a PUR of up to 500ml as normal! That protocol, using the 500ml cut off, was just recently published in the J Matern Fetal Neonatal Med in Dec 2023. PUR is classified into 2 groups: overt (AKA symptomatic) and covert (asymptomatic) urinary retention; overt PUR traditionally has been defined as an inability to spontaneously void 4-6 h after vaginal delivery or the need for re-catheterization 4- 6 h after catheter removal following cesarean section. What’s the recommended plan of care after diagnosing PUR? Does bethanechol help? Can peppermint oil vapor help? Well…this is SOME data on this! Listen in for details.
undefined
Feb 12, 2025 • 24min

PP Ibuprofen with HDP? “NEW info”.

The podcast dives into the evolving landscape of postpartum pain management using ibuprofen, revisiting past guidelines from ACOG. A new study highlights safety for patients with hypertensive disorders of pregnancy, revealing no significant impact on blood pressure. Discrepancies in fetal surveillance guidelines also come under scrutiny, reflecting the challenges faced by clinicians. The hosts emphasize the importance of understanding study timelines and offer insights on effective communication in medical practices, all while valuing listener feedback.
undefined
Feb 11, 2025 • 44min

The Survey Says....! (FULL EPISODE)

(We were made aware that this original posting had the last section DROPPED accidentally)...here is the full episode! Ahhh...TECHNOLOGY! *This is why AI will likely replace our production team...Just kidding production team, just kidding).Episode Details:Well, we typically focus on ONE or maybe TWO publications to highlight and review. However, in this episode, which we have decided to call, “Survey said…!”, we will go through some common and REAL WORLD “mental battles”regarding what is and what is not part of a diagnostic criteria. These are every day OBGYN things that we KNOW, but when asked to define them…we can easily get ourselves confused. We are going to clear these up…Game Show style!  First, when only one abnormal value is found in the two-step, 100-gram GTT,  it is called borderline GDM, or impaired glucose tolerance. But what is it called when there is an abnormal (failed) 1-Hour 50 gram, but completely normal 3-Hr 100-gram GTT? Is this also called “impaired glucose tolerance”? We….the Survey Said…! (Yep, we’ll get to that). Secondly, does the criteria for Preeclampsia with Severe Criteria include platelets of 100,000 or not? The Survey Said…! (Yep, we’ll cover that). We will also review the numbers for MVP oligo, for a “normal” postmenopausal ES, and MORE! Listen in for details!
undefined
Feb 10, 2025 • 34min

The Survey Says...! (PLEASE SEE UPDATED VERSION 2/11/25)

Well, we typically focus on ONE or maybe TWO publications to highlight and review. However, in this episode, which we have decided to call, “Survey said…!”, we will go through some common and REAL WORLD “mental battles” regarding what is and what is not part of a diagnostic criteria. These are every day OBGYN things that we KNOW, but when asked to define them…we can easily get ourselves confused. We are going to clear these up…Game Show style! First, when only one abnormal value is found in the two-step, 100-gram GTT, it is called borderline GDM, or impaired glucose tolerance. But what is it called when there is an abnormal (failed) 1-Hour 50 gram, but completely normal 3-Hr 100-gram GTT? Is this also called “impaired glucose tolerance”? We….the Survey Said…! (Yep, we’ll get to that). Secondly, does the criteria for Preeclampsia with Severe Criteria include platelets of 100,000 or not? The Survey Said…! (Yep, we’ll cover that). We will also review the numbers for MVP oligo, for a “normal” postmenopausal ES, and MORE! Listen in for details!
undefined
Feb 6, 2025 • 44min

Severe CHTN or Superimposed PreE w/Severe Features?

The podcast dives into the complexities of diagnosing severe hypertension in pregnant women, dissecting the tricky distinction between chronic hypertension and superimposed preeclampsia. Listeners learn about the significance of specific blood pressure thresholds and the risks of misclassification. The discussion emphasizes the importance of adhering to clinical guidelines for optimal maternal and fetal health. It also explores the challenges in interpreting blood pressure readings and the need for vigilance in treatment strategies.
undefined
Feb 4, 2025 • 38min

Eclampsia = Brain Scan?

According to the ACOG, eclampsia is a low frequency, high acuity emergent condition. The rate of an eclamptic seizure is 1/200 in those with preeclampsia without severe features but is 4 fold higher ( 4/200 ) in those with preeclampsia with severe features. Traditionally, “textbook eclampsia” management did not include cranial imaging. However, that consensus is changing! In this episode, we will review data making the case for a standardized approach to eclampsia, which includes universal non-contract cranial CT after eclampsia. We will highlight a Clinical Expert Series ACOG publication from July 2024 as well as an upcoming publication from Pregnancy Hypertension in March 2025 which makes the strong case for this radiological diagnostic tool. Listen in for details.
undefined
Feb 1, 2025 • 40min

“Sounds Reasonable”! 3 Things to Consider.

Well, in this episode we have a “3-in-1” subject review. Often in medicine, we find ourselves with some data to guide us, but definitely not a “predominance of evidence”. So in caring for our patients, we often come to the conclusion that doing a course of action can possibly help, and can't hurt... and therefore our plan “sounds reasonable”. That's the focus of our episode today! We're going to have fun with this one and cover three topics where we do have some data to guide us, but not our predominance of data that the dot leaving us to conclude that a plan of action “sounds reasonable”. 1. Can nitrous oxide be used for IUD/IUS insertion? 2. Should we follow total serum bile acids serially for ICP (new Jan 2025 data)? 3. And if IM Ceftriaxone is recommended as first-line RX for gonorrhea, can we give expedited partner therapy as an oral medication? Listen in for details!
undefined
Jan 28, 2025 • 38min

No Need for PP LMWH VTE Prophylaxis?

Dive into the complexities of postpartum venous thromboembolism (VTE) and its implications for maternal health. The discussion highlights a new study questioning the effectiveness of postpartum pharmacologic therapy. Discover the divergent guidelines from RCOG and ACOG, and the emphasis on personalized care. Additionally, explore nostalgic reflections on 'Welcome Back, Cotter,' blending humor with serious topics. This engaging conversation poses critical questions about VTE management and patient safety.
undefined
Jan 24, 2025 • 30min

"CNN" Update (Chapa News Network): 1. ACOG RSV-GBS Response, 2. TRD

This- is-CNN. No, that THAT CNN...This is Chapa News Network! WE have late-breaking news developments on 2 fronts: 1. The ACOG has released a clinical update (ACOG ROUNDS) in response to a recent study associating the RSV vaccine and GBS (we covered this study in a past episode). 2. The FDA has EXPANDED the label for an intranasal therapy for Treatment Resistant depression (TRD). Listen in for details.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app